mk-0616
merck
['cardio', 'merck']
in a phase 2 study, an oral pcsk9 inhibitor lowered ldl, non-hdl and apob to a similar extent seen in the injectable forms #acc23 #wccardio #cardiotwitter #cardiology 
The content you need, when you need it.